Start here if you're new
what it is
Corebridge sells retirement solutions and life insurance in the U.S.
how it gets paid
Last year Corebridge Fin made $18.5B in revenue. Individual Retirement was the main engine at $10.9B, or 59% of sales.
why growth slowed
Revenue fell 1.2% last year. A simultaneous commitment by the company to spend $500 million for a large portion of those shares being offered only slowed the resulting decline in.
what just happened
Corebridge printed $11.7B of quarterly revenue, but EPS was -$2.15.
At a glance
B++ balance sheet — above average — nothing keeping you up at night
6.8x trailing p/e — the market's not buying it — or you found a deal
3.1% dividend yield — cash in your pocket every quarter
9.8% return on capital — nothing to write home about
xvary composite: 40/100 — below average
What they do
Corebridge sells retirement solutions and life insurance in the U.S.
59% of 2024 adjusted pretax income came from Individual Retirement. 18% came from Group Retirement. 11% came from Life Insurance, and 12% came from Institutional Markets. That is four profit engines, not one trick. You are buying a business with 5,700 employees and two owners holding 45.4% combined.
How they make money
$18.5B
annual revenue · their business grew -1.2% last year
Individual Retirement
$10.9B
Group Retirement
$3.3B
Life Insurance
$2.0B
Institutional Markets
$2.2B
The products that matter
retirement savings and annuity products
Individual Retirement
$7.8B · 42% of disclosed segment revenue
it's the largest business in this snapshot at $7.8B, which makes it the clearest read-through for whether the recovery story is real.
largest segment
employer-sponsored retirement plans
Group Retirement
$6.1B · 33% of disclosed segment revenue
this $6.1B segment gives you workplace distribution at scale, which matters because insurers love sticky assets and payroll-linked contributions.
workplace channel
underwrites protection products
Life Insurance
$4.6B · 25% of disclosed segment revenue
it's a $4.6B business. smaller than retirement, still large enough to move earnings if claims, pricing, or investment results shift.
earnings swing factor
Key numbers
6.8x
trailing p/e
You are paying 6.8 times trailing earnings. That is cheap unless earnings fall faster than the market expects.
3.1%
dividend yield
You get 3.1% in cash each year. That helps while you wait for the stock to catch up.
9.8%
return on capital
Corebridge earns 9.8% on capital. That tells you the business is making acceptable returns, not heroic ones.
$9.4B
long-term debt
Debt of $9.4B sits ahead of shareholders. That limits how much of the business you truly own.
Financial health
B++
strength
- balance sheet grade B++ — above average financial health
- risk rank 3 — safer than 50% of stocks
- price stability 55 / 100
- long-term debt $9.4B (36% of capital)
- return on equity 22% — $0.22 profit for every $1 investors have put in
B++ — functional but not a standout on the balance sheet.
Total return vs. market
Return history isn't available for CRBG right now.
source: institutional data · return history unavailable
What just happened
missed estimates
Corebridge printed $11.7B of quarterly revenue, but EPS was -$2.15.
Revenue was up 116% from a year ago. The bottom line still showed a loss, so the quarter was big on sales and weak on earnings.
$11.7B
revenue
$2.15
eps
116%
revenue vs. last year
the number that mattered
The $11.7B revenue print matters because it was 116% above last year, but EPS was still negative at $2.15.
-
shares of coreb ridge have been especially volatile of late.
-
in early november, the company announced lackluster third-quarter financial results.then, just a day later, corebridge published details of a secondary offering of 32.6 million shares by aig, its former parent and previously its largest shareholder.
-
a simultaneous commitment by the company to spend $500 million for a large portion of those shares being offered only slowed the resulting decline in the stock.
-
by mid-november, around the time these transactions were likely to be wrapping up, the shares troughed at just under $28, or about 15% lower than their value to begin the month.
-
since then, the stock had recovered most of its recent declines, buoyed by improved equity markets and particularly strong advances among life insurance equities.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the #1 risk is the earnings rebound failing to hold.
high
earnings normalization stalls
the quarter showed $1.59 EPS, but the last four quarters still total a $0.53 loss per share.
if quarterly profitability slips again, the 39.6% growth forecast stops looking like a recovery and starts looking like wishful thinking.
med
cfo transition
chief financial officer Elias Habayeb is set to depart in April 2026.
finance leadership changes are rarely what makes an insurer work, but they can expose what was already not working.
med
capital return carrying the story
a $750M repurchase from AIG was announced in feb 2026, and buybacks help support the equity story.
if buybacks slow before earnings quality improves, you lose one of the cleanest supports under the stock.
low
spin-off clean-up risk
corebridge is still a relatively recent AIG spin-off, which means legacy systems, reporting complexity, and portfolio clean-up can linger.
this is not the loudest risk, but it can keep valuation cheap longer than a simple screen suggests.
between trailing losses, $9.4B of long-term debt, and a leadership transition, the cheap multiple only works if quarterly earnings stay positive.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
quarterly EPS staying above zero
one $1.59 quarter is the setup. a few more profitable quarters are the proof.
risk
cfo succession
Elias Habayeb departs in April 2026. you want a clean handoff, not accounting drama.
calendar
next earnings after the q4 beat
the next report matters more than the last one. rebounds become trends only when they repeat.
trend
institutional buying versus price weakness
260 buyers versus 158 sellers in 3q2025 says funds were leaning in. if that reverses, sentiment is changing.
Analyst rankings
short-term outlook
bottom 5%
momentum score 5 — the lowest rating. in human-speak: analysts think this could keep lagging in the near term even if the longer-term value case looks interesting.
risk profile
average
stability score 3 means middle-of-the-pack risk. not a bunker stock, not a meltdown candidate.
chart momentum
average
technical score 3 says the chart is not giving you a strong signal either way. the fundamentals have to do the work.
source: institutional data
Institutional activity
institutions have been net buying for 2 consecutive quarters — 260 buyers vs. 158 sellers in 3q2025. total institutional holdings: 0.5B shares. net buying for 2 quarters.
source: institutional data
Price targets
3-5 year target range
$27
$66
$32
current price
$47
target midpoint · +46% from current · 3-5yr high: $50 (+55% · 14% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive